from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0645c/mmaA1

LFCtreatmentdescriptionclass of inhibitor

0.960

Amikacinug/mL Amikacintranslation

1.121

Cap5-10ug/mL Capreomycintranslation

0.800

Rox10-50 ug/mL Roxithromycintranslation

0.268

SM2-5 ug/mL Streptomycintranslation

0.023

Tet5-10 ug/mL Tetracyclinetranslation

0.633

Rif0.2-5ug/mL Rifampicintranscription

0.414

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.389

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.395

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.478

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.037

Clofazimine10-13 ug/mL Clofaziminerespiration

0.092

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.995

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.110

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.010

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.374

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.314

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.480

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.703

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.521

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.516

KCN5-20 ug/mL Potassium cyaniderespiration

0.325

NaN30.2-2 mM Sodium aziderespiration

1.967

Nigericin50 uM Nigericinrespiration

-0.736

TRC10-150 ug/mL Triclosanrespiration

-0.241

TRZ10-25 ug/mL Thioridazinerespiration

-0.402

Valinomycin0.5-10 uM Valinomycinrespiration

0.716

ZnSO42 mM ZnSO4respiration

0.199

menadione6-10 ug/mL Menadionerespiration

-0.525

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.293

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.465

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.826

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.205

NRP_1Non-replicating persistence stage 1dosRassociated

0.097

Amp0.2mg/mL AmpicillincellWall

-0.204

Cephalexin20-100 ug/mL CephalexincellWall

0.553

Cerulenin0.32-5 ug/mL CerulenincellWall

0.632

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.179

EMB10-20 ug/mL EthambutolcellWall

-0.008

Eta12-40 ug/mL EthionamidecellWall

0.364

INH0.2-0.4 ug/mL IsoniazidcellWall

0.166

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.699

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.133

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.705

BZA0.12 mg/mL BenzamidearomaticAmides

-0.484

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.134

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.306

H2O24 mM hydrogen peroxideDNAdamaging

1.026

Levo10 ug/mL LevofloxacinDNAdamaging

0.011

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.555

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.351

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.159

UVUV-irradiationDNAdamaging

0.584

ARP41-4 ug/mL Antitubercular compound ARP4?

0.264

Antimycin12.5-50 ug/mL Antimycin A?

0.473

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.443

PA_110-50 ug/mL Antitubercular compound PA-1?

0.828

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.078

PA8240.2-2 ug/mL PA-824?

-0.740

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.512

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.203

Verapamil50 uM Verapamil?

-0.059

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.168

methoxatin10-20 ug/mL Methoxatin?